MedTrace Logo

Addressing Reproductive Coercion in HEalth Settings - Kenya

NCT03534401 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 659

Last updated 2023-02-13

No results posted yet for this study

Summary

The primary purpose of this research is to conduct a small matched cluster control trial of an intervention designed to address reproductive coercion and unintended pregnancy (ARCHES - Addressing Reproductive Coercion within Healthcare Settings) adapted to the Kenyan cultural and family planning healthcare context (ARCHES Kenya) so as to provide initial data regarding acceptability, feasibility and efficacy in this high-need LMIC context.

Conditions

  • Unintended Pregnancy
  • Family Planning
  • Intimate Partner Violence (IPV)

Interventions

BEHAVIORAL

ARCHES Kenya

ARCHES: Contraceptive counselors in intervention clinics will receiving training to ) provide counseling and education regarding risk of partner detection of contraceptive methods, and women's and girls' strategies to use contraceptive methods to minimize partner detection risk integrated into standard contraceptive counseling, b) make brief inquiries to allow clients the opportunity to disclose experiences of RC and IPV (i.e., screening), c) provide method-specific counseling based on this information and the method chosen by the client, d) provide supported linkage of IPV survivors to local IPV support services (i.e. warm referral), and e) offer palm-sized educational materials on RC and IPV, as well as IPV services to all clients.

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • International Planned Parenthood Federation

    collaborator OTHER

  • Population Council

    collaborator OTHER

  • University of California, San Diego

    lead OTHER

Principal Investigators

  • Jay G Silverman, PhD · UCSD Center on Gender Equity and Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-08-01
Completion
2020-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03534401 on ClinicalTrials.gov